CSE/CL (CSE/CL)

Canadian Securities Exchange: CSE/CL · CAD

CA$0.86

-0.01 (-1.1%)· Recorded snapshot

Market cap	319M
Revenue (ttm)	924.7M
Net income (ttm)	-143.3M
EPS (ttm)	-CA$0.40
Shares out	371M
Volume	4,315
Beta	1.81

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 924.7M
Net income (ttm): -143.3M
EPS (ttm): -CA$0.40
Market cap: 319M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-36.1

P25 n/aP50 n/aP75 n/a

ROIC7.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/CL indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-06
Employees	2,900
Employees change	140
Employees growth	5.07%
Enterprise value	CAD 977.7M
Exchange	Canadian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1990
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA22587M1068
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Market cap	CAD 319M
Next earnings date	2026-11-06
Price	CAD 0.86
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	cse/CL
Website	https://www.crescolabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	312.56x
Earnings yield	-45.95%
EV/EBIT	11.03x
EV/EBITDA	4.97x
EV/FCF	67.3x
EV/Sales	1.06x
FCF / EV yield	1.49%
FCF yield	4.52%
Industry forward P/E	34.37x
P/(OCF - SBC) ratio	8x
P/B ratio	0.86x
P/FCF ratio	22.13x
P/OCF ratio	5.24x
P/S ratio	0.35x
Price/EBITDA ratio	2.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.62%
EBITDA margin	17.07%
FCF margin	1.6%
Gross margin	49.92%
Operating margin	9.62%
Pretax margin	-15.92%
Profit margin	-15.5%
Profit per employee	CAD -49,419
Profitable quarters	1
Revenue per employee	CAD 318,853
ROA	3%
ROA (5Y)	3.76%
ROCE	5.57%
ROE	-36.06%
ROE (5Y)	-33.67%
ROIC	7.73%
ROIC (5Y)	8.79%
SBC / revenue	2.3%
Tax / revenue	1.37%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
FCF growth	-88.58%
Gross profit growth	-4.21%
Gross profit growth (Q)	4.43%
Gross profit growth 3Y	-1.83%
Gross profit growth 5Y	-1.45%
Net income growth quarters	2
Net income growth years	0
OCF growth	-63.27%
OCF growth (Q)	74.67%
OCF growth 3Y	-4.92%
OCF growth 5Y	17.16%
Operating income growth	-28.04%
Operating income growth (Q)	-47.41%
Operating income growth 3Y	28.15%
Operating income growth 5Y	-1.33%
Revenue growth	-4.95%
Revenue growth (Q)	5.94%
Revenue growth (QoQ)	14.55%
Revenue growth 3Y	-6.1%
Revenue growth 5Y	-1.06%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -47M
Depreciation and amortization	CAD 68M
EBIT	CAD 89M
EBITDA	CAD 157.8M
EPS	CAD -0.40
FCF per share	CAD 0.04
Financing cash flow	CAD -122.1M
Free cash flow	CAD 14.6M
Free cash flow minus SBC	CAD -6.7M
Gross profit	CAD 461.6M
Income taxes	CAD 12.7M
Investing cash flow	CAD -61.1M
Net borrowing	CAD -82.9M
Net cash flow	CAD -121.6M
Net income	CAD -143.3M
Operating cash flow minus SBC	CAD 40.3M
Operating income	CAD 89M
Revenue	CAD 924.7M
Stock-based compensation	CAD 21.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.66
Book value per share	CAD 1.37
Debt / EBITDA	4.26
Debt / equity	2.25
Debt / FCF	57.66
Goodwill	CAD 311.5M
Interest coverage	1.02
Long-term assets	CAD 1.4B
Long-term liabilities	CAD 1.2B
Net cash (debt)	CAD -794M
Net cash / market cap	-246.03%
Net debt / EBITDA	5.03
Net debt / equity	2.12
Net debt / FCF	54.46
Piotroski F-Score	5
Property, plant and equipment	CAD 605.8M
Shareholders' equity	CAD 374M
Tangible book value	CAD -261.8M
Tangible book value per share	CAD -0.70
Total assets	CAD 1.8B
Total cash	CAD 46.7M
Total debt	CAD 840.7M
Total liabilities	CAD 1.4B
WACC	9.85%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	CAD 344.7M
Current liabilities	CAD 193.2M
Current ratio	1.78
Inventory turnover	3.25
Net working capital	CAD 143.2M
Quick ratio	0.53
Working capital	CAD 153.3M
Working capital turnover	5.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.63%
Shareholder yield	-3.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 1.13
1D price change	-1.15%
1M price change	-18.87%
1M total return	-18.87%
1Y price change	-51.14%
1Y return CAGR	-51.16%
1Y total return	-51.14%
20-day SMA	CAD 0.89
200-day SMA	CAD 1.21
3M price change	-8.51%
3M total return	-8.51%
3Y price change	-46.25%
3Y return CAGR	-18.69%
3Y total return	-46.25%
50-day SMA	CAD 0.99
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 3.12
52-week high date	2025-12-18
52-week low	CAD 0.81
52-week low date	2026-10-20
5Y price change	-90.95%
5Y return CAGR	-38.15%
5Y total return	-90.95%
6M price change	-46.25%
6M total return	-46.25%
All-time high	CAD 22.20
All-time high date	2021-02-10
All-time low	CAD 0.60
All-time low date	2025-06-23
Average true range (ATR)	CAD 0.05
Average volume	78.8K
Beta (1Y)	1.55
Beta (2Y)	2.21
Beta (5Y)	1.81
Change from 52-week high	-72.44%
Change from 52-week low	6.17%
Change from all-time high	-96.13%
Change from all-time low	43.33%
Change from open	0%
Day's gap	-1.15%
Dollar volume	CAD 3,711
High price	CAD 0.86
Low price	CAD 0.86
Monthly RSI	40.88
Open price	CAD 0.86
Previous close	CAD 0.87
Price vs 150-day SMA	-23.83%
Price vs 20-day SMA	-3.59%
Price vs 200-day SMA	-28.81%
Price vs 50-day SMA	-13.08%
Relative volume	0.05
RSI	42.27
Sharpe ratio	0.06
Sharpe ratio (3Y)	0.24
Sharpe ratio (5Y)	-0.06
Sortino ratio	0.17
Sortino ratio (3Y)	0.46
Sortino ratio (5Y)	-0.03
Volume	4.3K
Weekly RSI	37.07
YTD price change	-48.19%
YTD total return	-48.19%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	343.8M
Shares change (QoQ)	29.68%
Shares change (YoY)	3.63%
Shares held by insiders	3.26%
Shares held by institutions	3.54%
Shares outstanding	371M

Deeper analysis on CSE/CL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/CL report

Is a complete CSE/CL research report available?

No complete published report is available for cse/CL (CSE/CL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/CL (CSE/CL)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/CL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/CL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/CL

Frequently asked questions